Cargando…
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
At present chronic liver disease (CLD), the third commonest cause of premature death in the United Kingdom is detected late, when interventions are ineffective, resulting in considerable morbidity and mortality. Injury to the liver, the largest solid organ in the body, leads to a cascade of inflamma...
Autores principales: | Tanwar, Sudeep, Rhodes, Freya, Srivastava, Ankur, Trembling, Paul M, Rosenberg, William M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962431/ https://www.ncbi.nlm.nih.gov/pubmed/31969775 http://dx.doi.org/10.3748/wjg.v26.i2.109 |
Ejemplares similares
-
The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
por: Trembling, Paul M., et al.
Publicado: (2020) -
The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study
por: Connoley, Declan, et al.
Publicado: (2021) -
Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
por: Trembling, P M, et al.
Publicado: (2014) -
Uncovering unsuspected advanced liver fibrosis in patients referred to alcohol nurse specialists using the ELF test
por: Rhodes, Freya, et al.
Publicado: (2021) -
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
por: Srivastava, Ankur, et al.
Publicado: (2019)